Concepedia

Justin Lucas

JL

Statistics

Publications

11

Citations

696

H-Index

10

Active since

2011

Affiliations

Pfizer (United States)(Current)

Justin Lucas is an author at Pfizer (United States) specializing in oncology, cancer immunotherapy, and medicine.

Publications per year

2011–2024

11

Publications

11

Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors

Wenyan Zhong, Jeremy S. Myers, Fang Wang et al. · BMC Genomics · 2020 · 179 citations · Full text

, , +17

A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions

Marc Damelin, Alexander J. Bankovich, Jeffrey Bernstein et al. · Science Translational Medicine · 2017 · 157 citations

, , +16

Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling

Justin Lucas, Tze‐chen Hsieh, H. Dorota Halicka et al. · International Journal of Oncology · 2018 · 104 citations · Full text

, , +17

Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions

Marc Damelin, Alexander J. Bankovich, Albert Park et al. · Clinical Cancer Research · 2015 · 87 citations · Full text

, , +17

A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers

Divya Mathur, Adam R. Root, Bozena Bugaj‐Gaweda et al. · Clinical Cancer Research · 2020 · 65 citations · Full text

, , +17

1–5 of 11